Go to content
UR Home

Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer

URN to cite this document:
DOI to cite this document:
Hatzipanagiotou, Maria Eleni ; Pigerl, Miriam ; Gerken, Michael ; Räpple, Sophie ; Zeltner, Verena ; Hetterich, Madeleine ; Ugocsai, Peter ; Inwald, Elisabeth Christine ; Klinkhammer-Schalke, Monika ; Ortmann, Olaf ; Seitz, Stephan
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 25 Jan 2024 05:16

This publication is part of the DEAL contract with Springer.


Purpose The optimal time to initiation of adjuvant chemotherapy (TTAC) for triple negative breast cancer (TNBC) patients is unclear. This study evaluates the association between TTAC and survival in TNBC patients. Methods We conducted a retrospective study using data from a cohort of TNBC patients diagnosed between January 1, 2010 to December 31, 2018, registered in the Tumor Centre Regensburg ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons